A Phase II Trial to Evaluate the Anti-psoriatic Efficacy and Tolerability of Tazarotene in a Gel Formulation in Patients With Mild to Moderate Nail Psoriasis - Parallel Group Comparison

NCT02235480 Phase 2 COMPLETED

The aim of this study is to determine the efficacy and safety of topical application of the gel compared to placebo in nail psoriasis.

Details

Lead sponsor	Almirall, S.A.
Phase	Phase 2
Status	COMPLETED
Enrolment	66
Start date	2014-02
Completion	2015-05

Conditions

• Nail Psoriasis

Interventions

• Experimental Tazarotene Gel
• Placebo

Primary outcomes

• % reduction in the Nail Psoriasis Severity Index ( NAPSI ) — Day85

Countries

Germany